Results 81 to 90 of about 45,614 (245)

Association of autoimmune diseases with biologic agents targeting type 2 immunity: An observational study using a claims database

open access: yesRheumatology &Autoimmunity, EarlyView.
This observational study assessed the association between anti‐type 2 biologic agents and the occurrence of autoimmune diseases using a large real‐world claims database. Anti‐IL‐5 and anti‐IgE therapies were associated with an increased occurrence of autoimmune diseases, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE ...
Shoichiro Inokuchi
wiley   +1 more source

Real‐Time Behavior Recognition Using a Legged Robot for Animal–Robot Interaction

open access: yesJournal of Field Robotics, EarlyView.
ABSTRACT Animal–robot interaction is an emerging interdisciplinary field that explores the dynamics between animals and robotic systems, as well as the design principles for effective engagement. While previous approaches have investigated animal responses to robotic stimuli, they have yet to integrate artificial intelligence (AI) for real‐time ...
Edoardo Fazzari   +3 more
wiley   +1 more source

Urticaria: An update on pathophysiology, diagnosis, and management

open access: yesTungs’ Medical Journal
Urticaria is a relatively common clinical skin disorder, and the condition is an inflammatory allergic immune response in the skin mucosa which increases the permeability of the subcutaneous capillaries.
Chieh Chen, Da-Ming Liao
doaj   +1 more source

Resource reallocation across successive systemic innovations: How Rolls‐Royce shaped the evolution of the turbojet, turboprop, and turbofan

open access: yesStrategic Management Journal, EarlyView.
Abstract Research Summary Despite the importance of resource reallocation in shaping a variety of strategic outcomes, strategy scholars have paid only limited attention to the processes by which firms reallocate their resources across successive systemic innovations.
Gino Cattani   +2 more
wiley   +1 more source

Chronic urticaria in children: Etiologies, Clinical Manifestations, Diagnosis and Treatment

open access: yesJournal of Pediatrics Review, 2013
Chronic urticaria is defined as a skin disease with central induration (wheal) and erythema formation around it (flare) that appears at least twice a week and remains at least for 6 weeks continually. The incidence of urticaria in children is about 0.1-3%
Javad Ghaffari   +4 more
doaj   +2 more sources

A Proposal to Center Relevance in Applied Linguistics Research: The Relevance‐to‐Practice (RTP) Framework

open access: yesTESOL Quarterly, EarlyView.
Abstract Considering applied linguistics as a problem‐centered discipline, we address an enduring challenge in the field: the need to ensure that research provides findings that can contribute to solving everyday challenges faced by language practitioners.
Hyun‐Bin Hwang, Matthew D. Coss
wiley   +1 more source

Clinical characteristics of immediate allergic adverse reactions to intravenous amoxicillin‒clavulanic acid in conscious dogs

open access: yesVeterinary Record, EarlyView.
Abstract Background Amoxicillin‒clavulanic acid (AMC) is one of the most frequently used antibiotics in small animal practice, and reports on adverse reactions are scarce. The aim of this study was to describe the clinical characteristics of immediate allergic adverse reactions to intravenous (IV) AMC in conscious dogs. Methods The medical records of a
Leonel Frutuoso, Anna Threlfall
wiley   +1 more source

Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO‐2b/3 and ALLEGRO‐LT Clinical Studies for Alopecia Areata

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Ritlecitinib is an oral JAK3/TEC family kinase inhibitor approved for individuals aged ≥ 12 years with severe alopecia areata. Here we report interim efficacy and safety results with ritlecitinib up to Month 24 in the Asian subpopulation from the ALLEGRO phase 2b/3 and ALLEGRO‐LT studies.
Rie Ueki   +13 more
wiley   +1 more source

Cost‐Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT The efficacy and safety of ritlecitinib, a dual inhibitor of Janus kinase 3 (JAK3) and tyrosine kinase expressed in hepatocellular carcinoma (TEC) family kinases, have been demonstrated in the ALLEGRO phase 2b/3 trial that enrolled patients aged ≥ 12 years with alopecia areata (AA) and ≥ 50% scalp hair loss.
Akira Yuasa   +8 more
wiley   +1 more source

The association between sexual dysfunctions and severity of symptoms in patients with chronic spontaneous urticaria

open access: yesAllergy, Asthma & Clinical Immunology, 2018
Agnieszka Skrzypulec-Frankel   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy